FIACCABRINO, SARA
 Distribuzione geografica
Continente #
NA - Nord America 236
EU - Europa 194
AS - Asia 42
Totale 472
Nazione #
US - Stati Uniti d'America 236
RU - Federazione Russa 77
IT - Italia 69
IE - Irlanda 17
CN - Cina 11
SG - Singapore 11
SE - Svezia 9
HK - Hong Kong 8
CH - Svizzera 7
JO - Giordania 7
IN - India 4
DE - Germania 3
FI - Finlandia 3
FR - Francia 2
GB - Regno Unito 2
NL - Olanda 2
RO - Romania 2
MY - Malesia 1
UA - Ucraina 1
Totale 472
Città #
Santa Clara 76
Chandler 20
Dublin 17
Fairfield 17
Wilmington 15
Woodbridge 14
Ashburn 12
Florence 12
Cambridge 10
Moscow 10
Singapore 10
Bern 7
Altamura 6
Houston 6
Lawrence 6
Pian di Scò 6
Rome 6
Seattle 5
Buffalo 4
Hong Kong 4
Medford 4
Milan 4
Mumbai 4
Princeton 4
Faenza 3
Helsinki 3
New York 3
Ann Arbor 2
Beijing 2
Bremen 2
Dearborn 2
Fiesole 2
Gambettola 2
London 2
Los Angeles 2
Paris 2
Pavia 2
San Gavino Monreale 2
Siena 2
Villa Minozzo 2
Ardea 1
Atlanta 1
Azzano Decimo 1
Bari 1
Boston 1
Brescia 1
Clifton 1
Falkenstein 1
Falls Church 1
Fuzhou 1
Hillsboro 1
Iasi 1
Imperia 1
Kent 1
Lugo di Vicenza 1
Malo 1
Ngau Wu Tok 1
Norwalk 1
Olgiate Comasco 1
Piacenza 1
Rozzano 1
Saviano 1
Sesto Fiorentino 1
Shanghai 1
St Petersburg 1
Washington 1
Totale 340
Nome #
Spectrum of ASXL1 mutations in primary myelofibrosis: Prognostic impact of the ASXL1 p.G646Wfs∗12 mutation 163
Involvement of RUNX1 Pathway Is a Common Event in the Leukemic Transformation of Chronic Myeloproliferative Neoplasms (MPNs) 133
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features 109
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms 72
Totale 477
Categoria #
all - tutte 1.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.489


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 0 7 6 4 3 2 1
2020/202147 3 1 1 27 0 1 4 0 5 0 5 0
2021/202228 0 0 5 0 0 2 0 3 4 0 5 9
2022/2023117 7 22 11 5 6 15 12 9 12 2 8 8
2023/202460 5 2 6 3 9 7 0 15 1 8 3 1
2024/2025187 4 23 16 49 60 35 0 0 0 0 0 0
Totale 477